6Pazhayattil GS, Shirali AC. Drug-induced impairment of renalfunction[ J]. Int J Nephrol Renovasc Dis, 2014, 7 : 457-468. 被引量：1
7Jang SM, Cerulli J,Grabe DW, et al. NSAID-avoidance educa-tion in community pharmacies for patients at high risk for acutekidney injury, upstate New York, 2011 [ J]. Prev Chronic Dis,2014, 11: E220. 被引量：1
8Abe M, Kaizu K, Matsumoto K. A case report of acute renal fail-ure and fulminant hepatitis associated with edaravone administra-tion in a cerebral infarction patient[ J]. Ther Apher Dial,2007,11(3) : 235-240. 被引量：1
9Ronco C, Levin A, Wamock DG, et al. Improving outcomes fromacute kidney injury(AKI) : Report on an initiative[ J]. Int J ArtifOrgans, 2007, 30(5) : 373-376. 被引量：1
10Hishida A. Clinical analysis of 207 patients who developed renaldisorders during or after treatment with edaravone reported duringpost-marketing surveillance [ J ]. Clin Exp Nephrol,2007,11(4): 292-296. 被引量：1
